UBS Group’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-40,890
| Closed | -$10.4K | – | 9090 |
|
|
2023
Q1 | $10.4K | Buy |
40,890
+24,900
| +156% | +$6.35K | ﹤0.01% | 6488 |
|
|
2022
Q4 | $18.9K | Buy |
+15,990
| New | +$18.9K | ﹤0.01% | 6532 |
|
|
2022
Q2 | – | Sell |
-3,292
| Closed | -$17K | – | 10170 |
|
|
2022
Q1 | $17K | Sell |
3,292
-1,077
| -25% | -$5.56K | ﹤0.01% | 6659 |
|
|
2021
Q4 | $27K | Buy |
+4,369
| New | +$27K | ﹤0.01% | 6407 |
|